Results 111 to 120 of about 5,144 (141)

Type IV pityriasis rubra pilaris treated with ixekizumab. [PDF]

An Bras Dermatol
Ferreirinha A, João A, Brito Caldeira M.   +2 more
europepmc   +1 more source

Biological Treatment of Psoriasis-Data So Far. [PDF]

Pharmaceuticals (Basel)
Matwiejuk M, Mikłosz A, Myśliwiec H, Chabowski A, Flisiak I.   +4 more
europepmc   +1 more source

Errors in Table 2.

JAMA Dermatol
europepmc   +1 more source

Psoriasis Flare Following Interleukin-17 (IL-17) Inhibition and Recent Streptococcal Infection: A Case Report Highlighting Management Complexity. [PDF]

Cureus
Hassan P, Gallagher M.
europepmc   +1 more source

Effects of GLP-1 Receptor Agonists on Psoriasis: An "Agent-Specific" Systematic Review of the Literature. [PDF]

J Clin Med
Marani A, Neri E, Morea E, Bertolla D, Gualdi G, Borghi A, Conti A, Amerio P.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Ixekizumab

Reactions Weekly
  +16 more sources

Ixekizumab

Reactions Weekly, 2019
  +10 more sources

Ixekizumab

Reactions Weekly, 2020
Caitriona Ryan, Roisin O’Connor
  +7 more sources